NCT05678205 2025-07-30A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid TumorsArtiva Biotherapeutics, Inc.Phase 1/2 Withdrawn
NCT06341647 2025-01-24Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201GC Cell CorporationPhase 1 Withdrawn
NCT04319757 2024-12-05ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid TumorsAcepodia Biotech, Inc.Phase 1 Completed12 enrolled
NCT05395052 2023-09-21FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid TumorsFate TherapeuticsPhase 1 Terminated5 enrolled
NCT03841110 2023-05-01FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid TumorsFate TherapeuticsPhase 1 Completed37 enrolled